Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Juan Kim

Dentist, Oral and Maxillofacial Surgery Kansas City, MO Doctor of Dentistry

NPI 1356717987 CMS profile 1335818

2101 Charlotte St Ste 310, Kansas City, MO 64108

Open in the dashboard

General payments

$6,512

46 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Juan Kim of Kansas City, MO is reported in the CMS Open Payments database as having received $6,512 across 46 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Dentist, Oral and Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $987 10
2024 General $4,716 26
2023 General $128 2
2022 General $244 3
2021 General $225 3
2020 General $100 1
2019 General $112 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Juan Kim
  • Dentist, Oral and Maxillofacial Surgery median
  • Middle half of Dentist, Oral and Maxillofacial Surgery
  • National median

In program year 2025, general payments to Juan Kim were reported at $987. Among 3,834 Dentist, Oral and Maxillofacial Surgery profiles paid that year, the median was $150 and the middle half received between $56 and $423.

Show as a table
Year Juan Kim Dentist, Oral and Maxillofacial Surgery median Middle half National median
2019 $112 $142 $50–$420 $163
2020 $100 $96 $36–$277 $114
2021 $225 $138 $45–$419 $132
2022 $244 $144 $48–$367 $149
2023 $128 $153 $55–$399 $160
2024 $4,716 $152 $50–$400 $164
2025 $987 $150 $56–$423 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AxoGen $2,405 8 payments
  2. Zimmer Biomet Holdings, Inc. $1,429 13 payments
  3. Stryker Corporation $1,387 14 payments
  4. Medical Device Business Services, Inc. $847 6 payments
  5. DePuy Synthes Sales Inc. $207 2 payments
  6. Kerecis Limited $133 1 payment
  7. PolyNovo North America LLC $91 1 payment
  8. Linvatec Corporation $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $4,125 13 payments
  2. Food and Beverage $2,387 33 payments
Products named General payments · program years 2019–2025
  1. Avance Nerve Graft $2,293 7 payments
  2. AxoGuard Nerve Connector $2,258 6 payments
  3. AXOGUARD NERVE PROTECTOR $2,258 6 payments
  4. Axoguard HA+ Nerve Protector $2,146 5 payments
  5. AXOGUARD NERVE CAP $2,146 5 payments
  6. NA $1,192 9 payments
  7. MATRIXCOMBO $847 6 payments
  8. AdvantageRib $687 2 payments
  9. TraumaOne $470 5 payments
  10. Kerecis Omega3 SurgiClose $133 1 payment
  11. Other $1,440 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

98

Median for Oral Surgery (Dentist only): 288

Drug cost

$260

Median for Oral Surgery (Dentist only): $1,122

Branded share of claims

19.4%

Median for Oral Surgery (Dentist only): 18.4%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Chlorhexidine Gluconate Generic 48 $142
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 19 $59
Amoxicillin Generic 20 $30
Ibuprofen Generic 11 $29

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 7 billing codes

Paid by Medicare

$1,279

Medicare's payments for the services billed

Medicare patients

13

Average age 68

Services billed

20

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Chronic kidney disease 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

46 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Oral and Maxillofacial Surgery in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record